Pharma Sales Performance (I.P. Pharma)
- Revenue dropped 30% in Q1 while order volume held flat — the metric everyone was watching showed nothing wrong.
- Root cause isolated by Q3 through a transaction-level and client-conversation audit.
The Problem
Q1 revenue dropped 30%, but order volume didn't move. On the number everyone tracked, nothing looked wrong — the business was reading a healthy signal off the wrong metric.
The Method
Went past order-volume reporting into transaction-level data and direct client conversations, tracing exactly where revenue and volume diverged instead of assuming the two moved together.
Recommendation & Outcome
Recommended and pushed through the process changes needed to close the gap once the root cause was traced. Revenue returned to its prior run-rate — a real, delivered result, not a projection, since this was resolved on the job rather than as a standalone analysis.
Why It Mattered
The real finding isn't the 30% drop, it's the flat order volume sitting next to it. A team that only tracks order count would have read “steady” as “healthy” and missed this entirely. Catching the disconnect, and closing it within two quarters, is the difference between reporting a problem and owning a fix.